Evidence map›Paper›PMID 39208444›Full record

ArticleThe Journal of infectious diseases2024

Impact of Human Leukocyte Antigen Allele-Killer Cell Immunoglobulin-like Receptor Partners on Sexually Transmitted Human Immunodeficiency Virus Type 1 Infection.

Carmen Serrano-Rísquez, Mohamed Omar, Norma Rallón, José Miguel Benito, Amparo Gómez-Vidal, Francisco J Márquez, Martina Alján, Antonio Rivero-Juárez, Ignacio Pérez-Valero, Antonio Rivero and 7 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. BeyondFrontiers in genetics · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Carmen Serrano-RísquezUnidad de Inmunogenética, Genética, Departamento de Biología Experimental, Universidad de Jaén.ORCID 0009-0000-8163-7596
Mohamed OmarServicio de Enfermedades Infecciosas y Microbiología Clínica, Complejo Hospitalario de Jaén.ORCID 0000-0002-7538-4980
Norma RallónHIV and Viral Hepatitis Research Laboratory, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid.
José Miguel BenitoHIV and Viral Hepatitis Research Laboratory, Hospital Universitario Rey Juan Carlos, Móstoles, Madrid.
Amparo Gómez-VidalServicio de Enfermedades Infecciosas y Microbiología Clínica, Complejo Hospitalario de Jaén.
Francisco J MárquezUnidad de Inmunogenética, Genética, Departamento de Biología Experimental, Universidad de Jaén.
Martina AljánUnidad de Inmunogenética, Genética, Departamento de Biología Experimental, Universidad de Jaén.
Antonio Rivero-JuárezInstituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía, Córdoba.ORCID 0000-0002-5813-6889
Ignacio Pérez-ValeroInstituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía, Córdoba.ORCID 0000-0002-3488-7135
Antonio RiveroInstituto Maimónides de Investigación Biomédica de Córdoba, Hospital Universitario Reina Sofía, Córdoba.ORCID 0000-0002-8643-4250
Faruk SinangilHIV Vaccine Program, Global Solutions for Infectious Diseases, Lafayette, California.
Irma SaulleDipartimento di Scienze Biomediche e Cliniche.ORCID 0000-0002-8600-2503
Mara BiasinDipartimento di Scienze Biomediche e Cliniche.ORCID 0000-0003-3671-4235
Mario ClericiDipartimento di Fisiopatologia Medico-Chirurgica e Trapianti, Università degli Studi di Milano.ORCID 0000-0001-5920-6191
Donald ForthalDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of California, Irvine.ORCID 0000-0001-6687-6775
Maria Eugenia SaézDepartamento de Investigacion Clinica, Centro Andaluz de Bioinformática, Sevilla, Spain.ORCID 0000-0001-9299-2534
Antonio CaruzUnidad de Inmunogenética, Genética, Departamento de Biología Experimental, Universidad de Jaén.ORCID 0000-0002-5788-7840

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human leukocyte antigen (HLA) class I/killer cell immunoglobulin-like receptor (KIR) genotypes influence human immunodeficiency virus type 1 (HIV-1) disease progression and viral load, but their role in primary infection is uncertain. Inconsistent results from previous studies suggest that the inoculum size and transmission route-parenteral versus sexual-may influence this association. We conducted a genome-wide association study in a population of people with HIV-1 and HIV-1-exposed seronegative individuals exposed to the virus through the sexual route. Our data do not support any role of the HLA/KIR system in susceptibility to sexually transmitted HIV-1 infection. The genetics basis of HIV-1 viral load and disease progression are distinct from the genetics of HIV resistance, a paradox worth exploring.

Indexed as

HIV-1HIV InfectionsHLA AntigensReceptors, KIRAdultAllelesFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansMaleMiddle AgedViral LoadHLA AntigensReceptors, KIRGWASHESNHIV-1HLAKIR

Identifiers

PMID39208444
PMCPMC11566224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.